WO2005018567A3 - Compounds and compositions for the treatment of diabetes and diabetes-related disorders - Google Patents

Compounds and compositions for the treatment of diabetes and diabetes-related disorders Download PDF

Info

Publication number
WO2005018567A3
WO2005018567A3 PCT/US2004/027200 US2004027200W WO2005018567A3 WO 2005018567 A3 WO2005018567 A3 WO 2005018567A3 US 2004027200 W US2004027200 W US 2004027200W WO 2005018567 A3 WO2005018567 A3 WO 2005018567A3
Authority
WO
WIPO (PCT)
Prior art keywords
diabetes
compounds
treatment
related disorders
compositions
Prior art date
Application number
PCT/US2004/027200
Other languages
French (fr)
Other versions
WO2005018567A2 (en
Inventor
Yamin Wang
Reina Natero
Original Assignee
Bayer Pharmaceuticals Corp
Yamin Wang
Reina Natero
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Pharmaceuticals Corp, Yamin Wang, Reina Natero filed Critical Bayer Pharmaceuticals Corp
Publication of WO2005018567A2 publication Critical patent/WO2005018567A2/en
Publication of WO2005018567A3 publication Critical patent/WO2005018567A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/28—Halogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention relates to novel compounds which are useful in the treatment of diabetes and diabetes-related disorders. The invention also relates to pharmaceutical compositions comprising said compounds, intermediates useful in the preparation of said compounds, and methods of preparation.
PCT/US2004/027200 2003-08-22 2004-08-20 Compounds and compositions for the treatment of diabetes and diabetes-related disorders WO2005018567A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US49710903P 2003-08-22 2003-08-22
US60/497,109 2003-08-22

Publications (2)

Publication Number Publication Date
WO2005018567A2 WO2005018567A2 (en) 2005-03-03
WO2005018567A3 true WO2005018567A3 (en) 2005-09-29

Family

ID=34216079

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2004/027200 WO2005018567A2 (en) 2003-08-22 2004-08-20 Compounds and compositions for the treatment of diabetes and diabetes-related disorders

Country Status (1)

Country Link
WO (1) WO2005018567A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007073555A1 (en) * 2005-12-20 2007-06-28 Gilead Colorado, Inc. Use of 4, 7-dihydrothieno [2, 3-b] pyridine compounds in the treatment of cardiovascular diseases
CN102746319B (en) * 2012-07-25 2015-08-05 中国科学院长春应用化学研究所 A kind of preparation method of thienopyridine ketone compounds

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6900205B2 (en) * 2001-09-26 2005-05-31 Bayer Pharmaceuticals Corporation 1,8-Naphthyridine derivatives and their use to treat diabetes and related disorders

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6900205B2 (en) * 2001-09-26 2005-05-31 Bayer Pharmaceuticals Corporation 1,8-Naphthyridine derivatives and their use to treat diabetes and related disorders

Also Published As

Publication number Publication date
WO2005018567A2 (en) 2005-03-03

Similar Documents

Publication Publication Date Title
WO2005086656A3 (en) Heteroarylaminopyrazole derivatives useful for the treatment of diabetes
WO2006124748A3 (en) Multicyclic compounds and methods of their use
WO2006086562A3 (en) Phenylazetidinone derivatives
WO2005046603A3 (en) Pyridine compounds
WO2006034154A3 (en) Salts of 5-azacytidine
TW200612892A (en) Novel compounds
WO2006037024A3 (en) Salts of decitabine
WO2005019258A3 (en) Compositions and methods for the treatment of immune related diseases
WO2004078116A3 (en) P38 inhibitors and methods of use thereof
TW200505837A (en) Novel compounds
TW200519075A (en) Novel compounds
WO2007052023A3 (en) Novel compounds
TW200630336A (en) Novel compounds
EP2305640A3 (en) Substituted diphenyl-ethers, -amines, -sulfides and -methanes for the treatment of respiratory diseases
TW200621690A (en) Novel compounds
WO2004108133A3 (en) Modulators of vr1 receptor
WO2005011592A3 (en) Substituted indazole-o-glucosides
WO2005012243A3 (en) Substituted indole-o-glucosides
WO2004047728A3 (en) Compositions and methods for the treatment of immune related diseases
WO2004039956A3 (en) Compositions and methods for the treatment of immune related diseases
WO2006131591A3 (en) An entacapone-containing oral dosage form
WO2004024068A3 (en) Novel composition and methods for the treatment of immune related diseases
WO2007044950A3 (en) Crystalline forms of docetaxel and processes for their preparation
WO2007076085A3 (en) Fused pyrimidones and thiopyrimidones, and uses thereof
WO2004106322A3 (en) Polymorphs of aripiprazole

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase
DPE2 Request for preliminary examination filed before expiration of 19th month from priority date (pct application filed from 20040101)